Accounting reportsPreviously
|
Name | APTEKA FORTE, OOO |
|---|
INN | 7734254940 |
|---|
KPP | 772701001 |
|---|
OGRN | 1037734003075 |
|---|
OKPO | 59871730 |
|---|
Address | 117452, G.MOSKVA, ul. Azovskaya, d. 24, pomesch. 12/1 |
|---|
Phone | 191-70-80 Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 21.10 | Additional activity | Manufacture of manmade fibres | | 21.20 | Additional activity | Manufacturers of drugs and pharmaceuticals and medical products | | All types of activities | | 46.18.1 | Additional activity | Agents specialized in the wholesale trade of pharmaceutical products, products used for medical purposes, perfume and cosmetics, including soap and detergents | | 46.18.3 | Additional activity | Agents specialized in the wholesale trade of machinery, equipment and tools used for medical purposes | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 47.75 | Additional activity | Retailing of cosmetics and personal hygiene products in specialized stores |
Registration date | 29.01.2003 |
|---|
Registering department | INSPEKTSIYA MNS ROSSII N 34 PO SZAO G.MOSKVY |
|---|
|
APTEKA FORTE, OOO (Moscow; INN 7734254940) was registered on 29 Jan 2003. The company's authorized capital as of July 1, 2012 was 20000 rub. Type of ownership of APTEKA FORTE, OOO - Limited liability companies. Form of ownership of APTEKA FORTE, OOO - Private property. Principal activities of APTEKA FORTE, OOO: retailing drugs in specialized stores (pharmacies) (47.73), manufacture of manmade fibres (21.10), manufacturers of drugs and pharmaceuticals and medical products (21.20). |
Economic indicators2023
Net loss (RA) of APTEKA FORTE, OOO made up 7.54 million RUB over 2023 compared to net profit of 9.70 million RUB over 2022, the company informed. Revenue decreased in the accounting period by 26.27% to 75.25 million RUB from 102.05 million RUB in 2022. 2022
Net profit (RAS) of APTEKA FORTE, OOO grew over 2022 by 36.57% to 9.70 million RUB from 7.11 million RUB over 2021, the company informed. Revenue decreased in the accounting period by 7.31% to 102.05 million RUB from 110.10 million RUB in 2021. 2021
Net profit (RAS) of APTEKA FORTE, OOO made up 7.12 million RUB over 2021 compared to net loss of 389.00 thousand RUB over 2020, the company informed. Revenue decreased in the accounting period by 3.49% to 110.10 million RUB from 114.07 million RUB in 2020. 2020
Net loss (RA) of APTEKA FORTE, OOO made up 389.00 thousand RUB over 2020 compared to net profit of 1.73 million RUB over 2019, the company informed. Revenue increased in the accounting period by 11.47% to 114.07 million RUB from 102.34 million RUB over 2019. 2019
Net profit (RAS) of APTEKA FORTE, OOO made up 1.73 million RUB over 2019 compared to net loss of 3.54 million RUB over 2018, the company informed. Revenue decreased in the accounting period by 23.26% to 102.34 million RUB from 133.35 million RUB in 2018. 2018
Net loss (RAS) of APTEKA FORTE, OOO dropped over 2018 3.27 times to 3.46 million RUB from 11.33 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 1.48% to 133.35 million RUB from 131.41 million RUB over 2017; cost of goods sold grew by 2.59% to 108.82 million RUB from 106.07 million RUB; sales loss decreased by 47.71% to 6.38 million RUB from 12.21 million RUB. 2017
Net loss (RAS) of APTEKA FORTE, OOO increased by 14.91% to 11.33 million RUB from 9.86 million RUB over 2016, the company informed. Revenue increased in the accounting period by 8.48% to 131.41 million RUB from 121.14 million RUB over 2016; cost of goods sold grew by 8.32% to 106.07 million RUB from 97.92 million RUB; sales loss grew by 9.41% to 12.21 million RUB from 11.16 million RUB. 2016
Net loss (RAS) of APTEKA FORTE, OOO increased 5.30 times to 9.86 million RUB from 1.86 million RUB over 2015, the company informed. Revenue increased in the accounting period by 17.22% to 121.14 million RUB from 103.34 million RUB over 2015; cost of goods sold grew by 21.01% to 97.92 million RUB from 80.92 million RUB; sales loss grew 2.22 times to 11.16 million RUB from 5.02 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|